(5Z,13E,15S)-9α,15-ジヒドロキシ-11-オキソプロスタ-5,13-ジエン-1-酸

危険有害性情報のコード(GHS)

• 絵表示(GHS)

  

• 注意喚起語

  Danger

• 危険有害性情報

  H302：飲み込むと有害

  H360：生殖能または胎児への悪影響のおそれ

• 注意書き

  P201：使用前に取扱説明書を入手すること。

  P308+P313：暴露または暴露の懸念がある場合：医師の診断/手当てを 受けること。

(5Z,13E,15S)-9α,15-ジヒドロキシ-11-オキソプロスタ-5,13-ジエン-1-酸 価格

(5Z,13E,15S)-9α,15-ジヒドロキシ-11-オキソプロスタ-5,13-ジエン-1-酸 化学特性,用途語,生産方法

• 外観

  白色～ほとんど白色, 結晶性粉末～粉末

• 溶解性

  メタノール, エタノールに易溶。アセトンに極めて溶けやすく、エタノールに溶け、水にほとんど溶けない。

• 用途

  薬理・生理作用研究用。

• 説明

  Prostaglandin D₂ (PGD₂) is the major eicosanoid product of mast cells and is released in large quantities during allergic and asthmatic anaphylaxis. Mastocytosis patients produce excessive amounts of PGD₂, which causes vasodilation, flushing, hypotension, and syncopal episodes. PGD₂ is also produced in the brain via an alternative pathway involving a soluble, secreted PGD-synthase also known as β-trace. In the brain, PGD₂ produces normal physiological sleep and lowering of body temperature. Further pharmacological actions include inhibition of platelet aggregation and relaxation of vascular smooth muscle. PGD₂ inhibits human ovarian tumor cell proliferation with an IC₅₀ of 6.8 μM.

• 使用

  Prostaglandin D2 is a fatty acid compound present in the human body. Elevated levels of localized Prostaglandin D2 has been linked to hair loss and growth inhibition. It has also been seen to contribute to the activity of allergic asthma.

• 定義

  ChEBI: A member of the class of prostaglandins D that is prosta-5,13-dien-1-oic acid substituted by hydroxy groups at positions 9 and 15 and an oxo group at position 11 (the 5Z,9alpha,13E,15S- s ereoisomer).

(5Z,13E,15S)-9α,15-ジヒドロキシ-11-オキソプロスタ-5,13-ジエン-1-酸 上流と下流の製品情報

(5Z,13E,15S)-9α,15-ジヒドロキシ-11-オキソプロスタ-5,13-ジエン-1-酸 生産企業

Global(69)Suppliers

41598-07-6, (5Z,13E,15S)-9α,15-ジヒドロキシ-11-オキソプロスタ-5,13-ジエン-1-酸 キーワード